Pharma Markets

Europe Irritable Bowel Syndrome Market and Competitive Landscape

By Fore Pharma | Published Date: June 7, 2020 | On-Demand Data

The latest research from Fore Pharma, Europe Irritable Bowel Syndrome Market and Competitive Landscape – 2020, provides comprehensive insights into Irritable Bowel Syndrome pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Irritable Bowel Syndrome market size and drug sales. It also provides insights into Irritable Bowel Syndrome epidemiology and late stage pipeline.

This research covers the following – Irritable Bowel Syndrome treatment options, Irritable Bowel Syndrome late stage clinical trials pipeline, Irritable Bowel Syndrome prevalence by countries, Irritable Bowel Syndrome market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:

– Countries: Germany, France, Italy, Spain, UK, Europe
– Irritable Bowel Syndrome pipeline: Find out drugs in clinical trials for Irritable Bowel Syndrome by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Irritable Bowel Syndrome epidemiology: Find out number of patients diagnosed (prevalence) with Irritable Bowel Syndrome by countries
– Irritable Bowel Syndrome drugs: Identify key drugs marketed and prescribed for Irritable Bowel Syndrome by countries, including trade name, molecule name, and company
– Irritable Bowel Syndrome drugs sales: Find out the sales value for Irritable Bowel Syndrome drugs by countries
– Irritable Bowel Syndrome market valuations: Find out the market size for Irritable Bowel Syndrome drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Irritable Bowel Syndrome drugs market share: Find out the market shares for key drugs by countries

Benefits of this Research: The research helps executives to

– Evaluate commercial market opportunities for Irritable Bowel Syndrome drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Irritable Bowel Syndrome market
– Develop in-depth knowledge of competition and markets
– Analyze Irritable Bowel Syndrome drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Irritable Bowel Syndrome market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies

Table of Contents


1. Irritable Bowel Syndrome Treatment Options
2. Irritable Bowel Syndrome Pipeline Insights
2.1. Irritable Bowel Syndrome Phase 3 Clinical Trials
2.2. Irritable Bowel Syndrome Phase 2 Clinical Trials
2.3. Irritable Bowel Syndrome Phase 1 Clinical Trials
3. Irritable Bowel Syndrome Epidemiology Analysis by Countries
4. Germany Irritable Bowel Syndrome Market Insights
4.1. Marketed Drugs for Irritable Bowel Syndrome in Germany
4.2. Germany Irritable Bowel Syndrome Market Size & Forecast
4.3. Germany Irritable Bowel Syndrome Drugs Sales Forecast
4.4. Germany Irritable Bowel Syndrome Market Share Analysis
5. France Irritable Bowel Syndrome Market Insights
5.1. Marketed Drugs for Irritable Bowel Syndrome in France
5.2. France Irritable Bowel Syndrome Market Size & Forecast
5.3. France Irritable Bowel Syndrome Product Sales Forecast
5.4. France Irritable Bowel Syndrome Market Share Analysis
6. Italy Irritable Bowel Syndrome Market Insights
6.1. Marketed Drugs for Irritable Bowel Syndrome in Italy
6.2. Italy Irritable Bowel Syndrome Market Size & Forecast
6.3. Italy Irritable Bowel Syndrome Product Sales Forecast
6.4. Italy Irritable Bowel Syndrome Market Share Analysis
7. Spain Irritable Bowel Syndrome Market Insights
7.1. Marketed Drugs for Irritable Bowel Syndrome in Spain
7.2. Spain Irritable Bowel Syndrome Market Size & Forecast
7.3. Spain Irritable Bowel Syndrome Product Sales Forecast
7.4. Spain Irritable Bowel Syndrome Market Share Analysis
8. UK Irritable Bowel Syndrome Market Insights
8.1. Marketed Drugs for Irritable Bowel Syndrome in UK
8.2. UK Irritable Bowel Syndrome Market Size & Forecast
8.3. UK Irritable Bowel Syndrome Product Sales Forecast
8.4. UK Irritable Bowel Syndrome Market Share Analysis
9. Europe Irritable Bowel Syndrome Market Insights
9.1. Europe Irritable Bowel Syndrome Market Size & Forecast
9.2. Europe Irritable Bowel Syndrome Product Sales Forecast
9.3. Europe Irritable Bowel Syndrome Market Share Analysis
10. Research Methodology

List of Tables


1: IrriBowel Syndrome Phase 3 Clinical Trials, Global, 2020
2: IrriBowel Syndrome Phase 2 Clinical Trials, Global, 2020
3: IrriBowel Syndrome Phase 1 Clinical Trials, Global, 2020
4: IrriBowel Syndrome Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for IrriBowel Syndrome in Germany, 2019
6: Germany IrriBowel Syndrome Market Size & Forecast ($mn), 2016 – 2025
7: Germany IrriBowel Syndrome Product Sales ($mn), 2016 – 2025
8: Germany IrriBowel Syndrome Market Events and Trends, 2016 – 2025
9: Marketed Drugs for IrriBowel Syndrome in France, 2019
10: France IrriBowel Syndrome Market Size & Forecast ($mn), 2016 – 2025
11: France IrriBowel Syndrome Product Sales ($mn), 2016 – 2025
12: France IrriBowel Syndrome Market Events and Trends, 2016 – 2025
13: Marketed Drugs for IrriBowel Syndrome in Italy, 2019
14: Italy IrriBowel Syndrome Market Size & Forecast ($mn), 2016 – 2025
15: Italy IrriBowel Syndrome Product Sales ($mn), 2016 – 2025
16: Italy IrriBowel Syndrome Market Events and Trends, 2016 – 2025
17: Marketed Drugs for IrriBowel Syndrome in Spain, 2019
18: Spain IrriBowel Syndrome Market Size & Forecast ($mn), 2016 – 2025
19: Spain IrriBowel Syndrome Product Sales ($mn), 2016 – 2025
20: Spain IrriBowel Syndrome Market Events and Trends, 2016 – 2025
21: Marketed Drugs for IrriBowel Syndrome in UK, 2019
22: UK IrriBowel Syndrome Market Size & Forecast ($mn), 2016 – 2025
23: UK IrriBowel Syndrome Product Sales ($mn), 2016 – 2025
24: UK IrriBowel Syndrome Market Events and Trends, 2016 – 2025
25: Europe IrriBowel Syndrome Market Size & Forecast ($mn), 2016 – 2025
26: Europe IrriBowel Syndrome Product Sales ($mn), 2016 – 2025

List of Figures


1: Irritable Bowel Syndrome Pipeline by Phase (%), Global, 2020
2: Irritable Bowel Syndrome Prevalence by Countries, 2016 – 2025
3: Germany Irritable Bowel Syndrome Market Size ($mn), 2016 – 2025
4: Germany Irritable Bowel Syndrome Product Sales ($mn), 2016 – 2025
5: Germany Irritable Bowel Syndrome Market Share by Drugs (%), 2019
6: Germany Irritable Bowel Syndrome Market – Future Market Share (%), 2025
7: France Irritable Bowel Syndrome Market Size ($mn), 2016 – 2025
8: France Irritable Bowel Syndrome Product Sales ($mn), 2016 – 2025
9: France Irritable Bowel Syndrome Market Share by Drugs (%), 2019
10: France Irritable Bowel Syndrome Market – Future Market Share (%), 2025
11: Italy Irritable Bowel Syndrome Market Size ($mn), 2016 – 2025
12: Italy Irritable Bowel Syndrome Product Sales ($mn), 2016 – 2025
13: Italy Irritable Bowel Syndrome Market Share by Drugs (%), 2019
14: Italy Irritable Bowel Syndrome Market – Future Market Share (%), 2025
15: Spain Irritable Bowel Syndrome Market Size ($mn), 2016 – 2025
16: Spain Irritable Bowel Syndrome Product Sales ($mn), 2016 – 2025
17: Spain Irritable Bowel Syndrome Market Share by Drugs (%), 2019
18: Spain Irritable Bowel Syndrome Market – Future Market Share (%), 2025
19: UK Irritable Bowel Syndrome Market Size ($mn), 2016 – 2025
20: UK Irritable Bowel Syndrome Product Sales ($mn), 2016 – 2025
21: UK Irritable Bowel Syndrome Market Share by Drugs (%), 2019
22: UK Irritable Bowel Syndrome Market – Future Market Share (%), 2025
23: Europe Irritable Bowel Syndrome Market Size ($mn), 2016 – 2025
24: Europe Irritable Bowel Syndrome Product Sales ($mn), 2016 – 2025
25: Europe Irritable Bowel Syndrome Market Share by Drugs (%), 2019
26: Europe Irritable Bowel Syndrome Market – Future Market Share (%), 2025

Format


Dispatch format is XLSX.

Purchase Checkout Added to cart
face
  • Contact Nick
  •  Email
  •  Contact
  • I was looking for specific epidemiology and utilization data for our emerging therapy situation analysis. It was time sensitive. Your team helped me with the right data and methodologies. Thank you very much.
    - Director, Big Pharma

    About

    • About us
    • Research Store
    • Research Store
    • News
    • Contact

    Trusted By
    Top Companies